1P-LSD Powder
1-propionyl-lysergic acid diethylamide Hemi-L-Tartrate / (6aR,9R)-N,N-Diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide Hemi-L-Tartrate
$140.00
1P-LSD (1-propionyl-lysergic acid diethylamide Hemi-L-Tartrate / (6aR,9R)-N,N-Diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide Hemi-L-Tartrate
) is closely related to LSD and is reported to produce near-identical effects. Little is known about the pharmacology of 1P-LSD, but it likely produces its psychedelic effects by acting on serotonin receptors in the brain. The original synthesis date of 1P-LSD is unknown.
Unlike most research chemicals, 1P-LSD has no prior record in the scientific literature. The first reports of 1P-LSD use surfaced in 2015 following its appearance on the online research chemical market. It was marketed as a legal alternative to LSD alongside other novel lysergamides like ALD-52, ETH-LAD, and AL-LAD.
It is similar to LSD and is named for the propionyl group bound to the nitrogen of the polycyclic indole group of LSD.
Propionyl consists of the carbonyl chain CH3CH2CO- bound to an amino group. 1P-LSD is homologous to ALD-52, which holds an acetyl group bound to the nitrogen instead of the propionyl group bound at the same location.
Oral | |
|---|---|
Light | 25-50ug |
Common | 50-125ug |
Strong | 125-200ug |